The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Privia Health Group Inc. shares valued at $481,781 were sold by Sullivan William M on May 12. At $26.54 per share, Sullivan William M sold 18,153 shares. The insider’s holdings dropped to 5,673,861 shares worth approximately $138.67 million following the completion of this transaction.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
Also, Mehrotra Parth sold 225 shares, netting a total of over 6,300 in proceeds. Following the sale of shares at $28.00 each, the insider now holds 138,457 shares.
Before that, Sullivan William M had sold 1,300 shares from its account. In a trade valued at $39,091, the Director traded Privia Health Group Inc. shares for $30.07 each. Upon closing the transaction, the insider’s holdings decreased to 1,300 shares, worth approximately $139.11 million.
Analyzing PRVA Stock Performance
On Thursday, Privia Health Group Inc. [NASDAQ: PRVA] plunged -3.36% to $24.44. The stock’s lowest price that day was $23.25, but it reached a high of $25.22 in the same session. During the last five days, there has been a drop of approximately -3.17%. Over the course of the year, Privia Health Group Inc. shares have jumped approximately 7.62%. Shares of the company reached a 52-week high of $30.15 on 05/09/23 and a 52-week low of $20.64 on 01/06/23. A 50-day SMA is recorded $26.88, while a 200-day SMA reached $29.11. Nevertheless, trading volume fell to 1.22 million shares from 0.63 million shares the previous day.
Support And Resistance Levels for Privia Health Group Inc. (PRVA)
According to the 24-hour chart, there is a support level at 23.39, which, if violated, would cause prices to drop to 22.33. In the upper region, resistance lies at 25.36. The next price resistance is at 26.27. RSI (Relative Strength Index) is 36.27 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.32, which suggests the price will decrease in the coming days. Percent R is at 82.75%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Privia Health Group Inc. subject to short interest?
Stocks of Privia Health Group Inc. saw a sharp steep in short interest on Apr 27, 2023 dropping by -0.17 million shares to 1.98 million. Data from Yahoo Finance shows that the short interest on Mar 30, 2023 was 2.15 million shares. A decline of -8.59% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.31 of the overall float, the days-to-cover ratio (short ratio) decline to 3.31.
Which companies own the most shares of Privia Health Group Inc. (PRVA)?
According to The Vanguard Group, Inc. filings, the company currently owns 5,384,307 shares, which is about 4.68% of the total PRVA shares outstanding. The investor’s shares have appreciated by 90,490 from its previous 13-F filing of 5293817.0 shares. BlackRock Fund Advisors acquire a 10.63% interest valued at $98.96 million while Point72 Asset Management LP purchased a 1,314,582 stake. A total of -69,782 shares of Privia Health Group Inc. were bought by Newton Investment Management Nort during the quarter, and -22,522 were sold by T. Rowe Price Investment Manageme. In its current portfolio, Principal Global Investors LLC holds 2,298,001 shares valued at $63.49 million.
In terms of Privia Health Group Inc. share price expectations, FactSet research, analysts set an average price target of $38.82 in the next 12 months, up nearly 58.17% from the previous closing price of $25.29. Analysts anticipate Privia Health Group Inc. stock to reach $45.00 by 2023, with the lowest price target being $30.00. In spite of this, 18 analysts ranked Privia Health Group Inc. stock as a Buy at the end of 2023.